Skip to main content

Advertisement

Table 4 Congruency of treatment recommendations for skin infections in children with national commensal S. aureus resistance rates

From: Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureusin the community

  Topical AB Resistance rate* First choice systemic AB Resistance rate* Second choice systemic AB Resistance rate*
Impetigo
Austria Fusidic acid 4.3 Cephalosporin No data Amoxicillin + clavulanic acid 0
Belgium Fusidic acid 0 Flucloxacillin 0 Clarithromycin 16.6
France No guideline
Hungary No guideline
Netherlands Fusidic acid 0.5 Flucloxacillin 0 Azithromycin 5.9
Spain No guideline
Sweden Retapamulin 0 Cefadroxil No data Flucloxacillin 0
UK Fusidic acid No data Flucloxacillin No data Clarithromycin No data
Cellulitis
Austria No guideline
Belgium    Flucloxacillin 0 No second choice
France No guideline
Hungary No guideline
Netherlands    Clarithromycin 4.2 Azithromycin 5.9
Spain No guideline
Sweden No guideline
UK    Flucloxacillin No data Ery/Clarithromycin No data
Folliculitis and Furuncle
Austria    Cephalosporin No data Amoxicillin + Clavulanic acid 0
Belgium No guideline
France No guideline
Hungary No guideline
Netherlands No guideline
Spain No guideline
Sweden No guideline
UK    Flucloxacillin No data Ery/Clarithromycin No data
  1. *A recommendation is congruent if the resistance rate in S. aureus to that antibiotic is <20%.